Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension

Oregon Health & Science University (OHSU)

Status: Withdrawn

Conditions: Afib; Hypertension

Treatments: Procedure: Renal Artery denervation

Study type: Interventional

Funder types: Other

Identifiers

NCT01952925

RA-D-9699

Details and patient eligibility

About

The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hypertensive patients scheduled for afib ablation
• Patient taking one or more BP medication

Exclusion criteria

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

Combined afib ablation and RA denervation

Experimental group

Description:

Patients with atrial fibrillation and resistant hypertension will be enrolled and undergo a single procedure consisting of pulmonary vein isolation and renal artery denervation.

Treatment:

Procedure: Renal Artery denervation